Comprehensive analysis reveals that P4HA3 is a prognostic and diagnostic gastric cancer biomarker that can predict immunotherapy efficacy
2024 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-024-73784-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
12
Citations
2
h-index
0
i10-index
Meihan Liu is an academic researcher from North Sichuan Medical University. The author has contributed to research in topics: Ferroptosis and cancer prognosis & RNA modifications and cancer & Cancer Immunotherapy and Biomarkers. The author has an h-index of 2, co-authored 8 publications.
https://doi.org/10.1038/s41598-024-73784-z
https://doi.org/10.1007/s12672-025-03768-6
Click to start Chat